NYLIM
DXCM icon

New York Life Investment Management’s DexCom DXCM Stock Holding History

New York Life Investment Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.43M Buy
65,799
+8,480
+15% +$565K 0.03% 372
2026
Q1 		$3.6M Buy
57,319
+608
+1% +$42.3K 0.03% 407
2025
Q4 		$3.76M Sell
56,711
-482
-0.8% -$31.2K 0.03% 376
2025
Q3 		$3.85M Sell
57,193
-1,511
-3% -$120K 0.03% 386
2025
Q2 		$5.12M Buy
58,704
+543
+0.9% +$42.6K 0.05% 324
2025
Q1 		$3.97M Sell
58,161
-445
-0.8% -$36.3K 0.04% 366
2024
Q4 		$4.56M Sell
58,606
-600
-1% -$44.4K 0.04% 345
2024
Q3 		$3.97M Sell
59,206
-1,338
-2% -$110K 0.04% 411
2024
Q2 		$6.86M Buy
60,544
+2,211
+4% +$280K 0.07% 256
2024
Q1 		$8.09M Sell
58,333
-2,141
-4% -$269K 0.08% 226
2023
Q4 		$7.5M Sell
60,474
-118
-0.2% -$12.1K 0.08% 226
2023
Q3 		$5.65M Sell
60,592
-245
-0.4% -$27.6K 0.06% 284
2023
Q2 		$7.82M Sell
60,837
-172
-0.3% -$20.8K 0.08% 230
2023
Q1 		$7.09M Sell
61,009
-124
-0.2% -$13.9K 0.08% 256
2022
Q4 		$6.92M Sell
61,133
-1,014
-2% -$111K 0.08% 253
2022
Q3 		$5.01M Sell
62,147
-420
-0.7% -$35.6K 0.06% 307
2022
Q2 		$4.66M Buy
+62,567
New +$5.71M 0.05% 324

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

New York Life Investment Management's DXCM Position: Q2 2026 in Review

New York Life Investment Management increased its DexCom (DXCM) stake by 15% in Q2 2026, buying an estimated $565K and bringing the position to 65,799 shares worth $4.43M. The position accounts for 0.03% of the portfolio, ranked #372.

New York Life Investment Management first reported a position in DXCM in Q2 2022 and has held it in 17 quarters since. The position peaked at $8.09M in Q1 2024. 711 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • New York Life Investment Management held 65,799 shares of DexCom worth $4.43M as of Q2 2026.
  • New York Life Investment Management bought 8,480 DexCom shares in Q2 2026, an estimated $565K.
  • DexCom made up 0.03% of New York Life Investment Management's portfolio in Q2 2026, its #372 holding.
  • New York Life Investment Management first reported a position in DexCom in Q2 2022 and has held it in 17 quarters since.
  • New York Life Investment Management's DexCom position peaked at $8.09M in Q1 2024.
  • 711 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.